返回 Agenda
[V4-S5] New Developments on Microbiome Research
Session Chair(s)
Koichiro Yuji, MD, PHD, FACP
Project Associate Professor, The Institute of Medical Science, Japan
The human body is colonized by a vast number of microbes, collectively referred to as the human microbiota. Each person’s microbiome is unique, and it impacts health and diseases, such as obesity, inflammatory bowel disease (IBD), diabetes mellitus, metabolic syndrome, atherosclerosis, alcoholic liver disease (ALD), colon cancer, and autoimmune disease. Metagenomic whole genome shotgun sequencing provided insights into the functions and pathways present in the human microbiome, and microbiome-derived biomarkers, drug targets, and bioactive molecules as potential treatments and companion diagnostics have been developed. In this session, the perspective on microbiome research and utilization will be discussed.
Speaker(s)
Seiya Imoto, PHD
Professor, Health Intelligence Center, The Institute of Medical Science, The University of Tokyo, Japan
Metagenome Analysis of Intestinal Bacteriome and Virome
Kosuke Fujimoto, PHD
Project Associate Professor, The Institute of Medical Science, The University of Tokyo, Japan
New Developments on Microbiome Research
Takayoshi Hisada
, TechnoSuruga Laboratory Co., Ltd., Japan
Use of Gut Microbiota Analyses and Metabolite Measurements